Corpus ID: 28272217

Kaletra approved in Canada.

@article{2001KaletraAI,
  title={Kaletra approved in Canada.},
  author={},
  journal={TreatmentUpdate},
  year={2001},
  volume={12 11},
  pages={
          1-2
        }
}
  • Published 2001
  • Medicine
  • TreatmentUpdate
On March 9, 2001, Health Canada granted permission to Abbott Laboratories for the sale of Kaletra (a combination of protease inhibitors lopinavir and ritonavir), formerly known as ABT-378/r, for the treatment of HIV infection in adults and children six months or older. Kaletra was approved for sale in the U.S. in September 2000.